MD&M West 2022 on 3D printing, biomaterials, robotics, digital health

Medical Design & Manufacturing (MD&M) West, the largest medtech event in North America and hosted annually by Informa Markets – Engineering, unveils its educational programming for Design. Engineer. To construct. Conference. Speakers include experts from Medtronic, NXT Biomedical, Canary Medical, Galen Robotics, Edward Life Sciences, Philips, Tech Coast Angels, Stryker, Ethicon Endo-Surgery, AtriCure and UCLA BioDesign. Additionally, four partners – MedtechWomen, the Association for the Advancement of Medical Instrumentation (AAMI), Chemical Angel Network (CAN), and the Society of Plastics Engineers – Medical Plastics Division – will discuss the latest in the development of medtech, medical plastics, quality, and regulatory products at the two-day 9-title conference.

Taking place at the Anaheim Convention Center from April 12-14, 2022, MD&M West is one of five co-located trademarks for the one-stop-shop event called “IME West”, which also includes WestPack, Automation Technology Expo (ATX) West, Design & Manufacturing (D&M) West and Plastec West.

Mike Guerra, CEO of California Life Sciences (CLS), said of the event, “Coming together at this event will help the medical device community connect through educational sessions and discover new business partnerships on the exhibition floor, which is critical to our industry’s mission advancement.As medical device technology evolves in the life sciences sector, in-person connection is essential to accelerate the adoption of new technologies and new work processes that will improve the delivery of patient care.We are proud to partner with MD&M West and look forward to supporting the upcoming event that will help drive the science industry forward. the life.

Adrienne Zepeda, Group Events Director, MD&M West, added, “Even amid unprecedented challenges, we continue to see vital new innovations and exciting partnerships emerge that are fueling the multi-hundred-billion dollar industry. We are so proud to announce our conference partners who are to take the stage and share valuable insights and equip our attendees with sought-after solutions to improve product speed to market, inject new materials and technologies into devices, strengthen relationships with industry and accelerate trade.

The selected content of the conference is described below:

Panel: Development of innovative medical devices for dynamic market segments

MedtechWomen (Tuesday April 12, 4:00 p.m.)

New ideas, new scientific discoveries and new manufacturing technologies are generating new products and changing the way these products are designed and developed. The COVID-19 pandemic has imposed intense challenges on design and engineering teams, tasking them with rapidly pivoting products while simultaneously reinventing teamwork via remote access. Meanwhile, the growth of connected and data-driven products is expanding the range of skills and resources needed to produce the average medical device. Join our panel of industry experts who will discuss the challenges and opportunities of building market-leading products through emerging and rapidly changing applications.

Speakers from Dyad Engineering, UserWise, Materna Medical, Beacon Launch Partners and Simplexity Product Development.

Keynote: The science of predictive healthcare and the role of nano-polymers and medical plastics.

MiniTec by SPE (Tuesday, April 12, 8:00 a.m.)

Predictive medicine has its roots in early warning systems and early detection by diagnosis. Prognostic devices are a new breed of diagnostic devices that not only detect and diagnose disease, but predict and in many ways prevent the onset of disease. Imagine a point-of-care device that can detect BNP, a cardiac marker produced by the heart in minute amounts before the onset of arrhythmia. Then the doctor can prevent the disease by modifying the patient’s lifestyle, diet, and exercise. Early forays into predictive medicine more than a decade ago have spawned a new generation of predictive methods and prognostic medical devices. ctDNA liquid biopsy techniques (which detect cancer at very early stages and can pinpoint the location of the tumor) and metabolomic biosensors (which prevent strokes through a combination of bioelectronics, data science and IA) to tumor-hunting nanobots and scissor-based CRISPR (which snuff out faulty genes before disease onset), these methodologies are making expert-level preventative care accessible to millions of people at risk. Even in the Covid-19 pandemic, medical-grade plastics have had a significant impact – the most exciting development is the use of medical nano-polymers formed into carriers that prevent the mRNA vaccine from being destroyed by the body’s own defenses before they can do their job! The driving force behind all of this is Medical Plastics.

Speaker from mFluiDx.

Debate: Maintaining a Validated State for Connected Medical Devices, SaMD and DTx in the Age of Chaotic Innovation

AAMI (Wednesday, April 13, 8:30 a.m. – 5:00 p.m.)

From AI/ML to smartphones to cloud computing and web services, MedTech faces a growing imperative to leverage these technologies to support essential functions of a regulated medical device. The medical device manufacturer that creates and operates these new technologies admirably emphasizes continuous improvement, but is often not compatible with traditional MedTech approaches to regulated change management. As engineers, regulators and scientists, we can no longer ignore this uncomfortable truth. Instead, we need to adapt to a new set of software architectural approaches, best practices, and systems thinking, taking a more modern approach to device security and what validated state means.

Speakers from Philips and Orthogonal.

Keynote: Innovation Requirements: More than Materials Science and Biomedical Engineering

Chemical Angel Network (Wednesday, April 13, 8:30 a.m. – 5:00 p.m.)

The three-legged stool of medical device innovation requires great technical ability, of course, but also a deep understanding of the associated medicine (anatomy, pathology, procedural knowledge, outcomes, standards of care, clinical trials) and innovation business (patents, fundraising, management, strategy). These elements will be highlighted as the story of the development of the TAVR is told; the twists and turns of technological challenges, patents, difficult fundraising, difficult regulators and difficult strategic choices. Join industry-leading innovator Stanton Rowe as he discusses:

  • How to think about customer needs when customers don’t know what they need
  • Barriers to innovation – some technical, some market related
  • If you know the customer you serve, decisions about strategy are so much easier

Speaker from NXT Biomedical

Diagnostic Product Development – From Concept to Market

Lishan Aklog, MD, President and CEO, PAVmed Inc. (Tuesday, April 12, 4:00 p.m.)

The healthcare system has been enhanced post-Covid with a newly formed and expansive market for diagnostic tests that meets the needs of patients, clinical staff and, most importantly, payers. Home diagnostics is here to stay, but taking an IVD product from concept development to market is fraught with many questions and challenges. Join industry expert Dr. Lishan Aklog as he shares both trials and successes and gives you ideas on how to avoid problem areas.

Register here to get a conference pass today and learn about the latest technologies and solutions available on the market from the best experts in the medical technology industry.

Follow IME West on social media and join the conversation. #IMEWest #DiscoverEngineerBuild

Informa Markets’ Engineering is the publisher of MD+DI.

About Hector Hedgepeth

Check Also

Study investigates cause of lymphopenia as seen in COVID-19 patients

In a recent study published on Research Square* preprint server, researchers explored the underlying mechanism …